Ventilation-Perfusion Matching in Early-stage Prone Position Ventilation

April 17, 2023 updated by: Peking Union Medical College Hospital

Ventilation-Perfusion Matching in Early-stage Prone Position Ventilation: A Comparison Between COVID-19 ARDS and ARDS From Other Etiologies

Prone positioning has been widely used in critical care medicine to improve oxygenation in patients with acute respiratory distress syndrome (ARDS). This study aimed to compare the effect of pronation on lung ventilation-perfusion matching between COVID19-associated acute respiratory distress syndrome (CARDS) and ARDS from other etiologies (non-CARDS) using electrical impedance tomography (EIT).

Study Overview

Status

Completed

Detailed Description

In this prospective study, both COVID19-associated ARDS (CARDS) patients and patients with ARDS from other etiologies (non-CARDS) were enrolled. Electrical impedance tomography (EIT) was used to evaluate the changes in ventilation and perfusion between supine and prone positions. Baseline values of the area of DeadSpace, shunt, ventilation-perfusion matching (VQmatch) were identified at the time of enrollment. Within the defined VQmatch region, the global inhomogeneity index (VQmatch-GI) was calculated to assess the degree of uniformity within the region. Prone position was applied immediately after the baseline data were collected. After 2 hours of proning, another EIT examination was conducted. Parameters such as DeadSpace, shunt, VQmatch, and other common measurements before and after pronation were taken and compared to evaluate the effect of prone positioning on CARDS and non-CARDS patients.

Study Type

Observational

Enrollment (Actual)

29

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100730
        • PUMC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population includes COVID19-associated ARDS patients and ARDS patients of other etiologies in the intensive care unit.

Description

Inclusion Criteria:

  • Above the age of 18
  • Diagnosed with ARDS based on the Berlin Definition of ARDS
  • Under mechanical ventilation

Exclusion Criteria:

  • Contraindications to EIT examination and prone position
  • Refusal of signing the informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
COVID19-associated ARDS (CARDS)
This group included COVID19 patients with acute respiratory distress syndrome. Patients were put under prone position while their pulmonary function was measured using EIT before and after proning.
Non-COVID19-associated ARDS (non-CARDS)
This group included patients with acute respiratory distress syndrome from other etiologies. Patients were put under prone position while their pulmonary function was measured using EIT before and after proning.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DeadSpace
Time Frame: 3 months
The area of Deadspace will be assessed using electrical impedance tomography
3 months
Shunt
Time Frame: 3 months
Shunt will be assessed using electrical impedance tomography
3 months
Ventilation-perfusion matching (VQmatch)
Time Frame: 3 months
VQmatch will be assessed using electrical impedance tomography
3 months
Global inhomogeneity index (VQmatch-GI)
Time Frame: 3 months
Within the defined VQmatch region assessed by electrical impedance tomography, the global inhomogeneity index (VQmatch-GI) was calculated to assess the degree of uniformity within the region.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ventilation
Time Frame: 3 months
The ventilation of the lungs is assessed by electrical impedance tomography before and after prone positioning.
3 months
Perfusion
Time Frame: 3 months
The perfusion of the lungs is assessed by electrical impedance tomography before and after prone positioning.
3 months
Center of Ventilation (CoV)
Time Frame: 3 months
The center of ventilation of the lungs is assessed by electrical impedance tomography before and after prone positioning.
3 months
Standard deviation of regional ventilation delay
Time Frame: 3 months
The standard deviation of regional ventilation delay of the lungs is assessed by electrical impedance tomography before and after prone positioning.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yun Long, MD, Peking Union Medical College

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 12, 2021

Primary Completion (Actual)

April 12, 2021

Study Completion (Actual)

April 12, 2021

Study Registration Dates

First Submitted

April 5, 2023

First Submitted That Met QC Criteria

April 17, 2023

First Posted (Actual)

April 18, 2023

Study Record Updates

Last Update Posted (Actual)

April 18, 2023

Last Update Submitted That Met QC Criteria

April 17, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome

Subscribe